Dianthus Therapeutics (DNTH) Shares Issued (2018 - 2025)
Dianthus Therapeutics' quarterly Shares Issued came in at $315000.0 in Q3 2025, up 199.06% year-on-year from $105331.2 in Q3 2024, and up 346.09% quarter-over-quarter from -$128000.0 in Q2 2025.
Dianthus Therapeutics has reported Shares Issued for 8 years, with the latest figure at $315000.0 in Q3 2025.
- For the quarter ending Q3 2025, Shares Issued rose 199.06% year-over-year to $315000.0; the trailing twelve-month figure through Sep 2025 stood at $39.5 million (changed N/A YoY), and the FY2024 full-year result was $39.2 million, up 783900.0% from the prior year.
- Shares Issued for Q3 2025 stood at $315000.0, up from -$128000.0 in the prior quarter.
- The five-year high for Shares Issued was $39.2 million in Q4 2024, with the low at -$3.3 million in Q4 2021.
- Average Shares Issued over 5 years is $3.0 million, with a median of $129000.0 recorded in 2025.
- Year-over-year, Shares Issued tumbled 6460.0% in 2024 and soared 199.06% in 2025.
- Tracing DNTH's Shares Issued over 5 years: stood at -$3.3 million in 2021, then soared by 98.51% to -$49000.0 in 2022, then jumped by 110.2% to $5000.0 in 2023, then surged by 783900.0% to $39.2 million in 2024, then sank by 99.2% to $315000.0 in 2025.
- The last three Shares Issued figures came in at $315000.0 (Q3 2025), -$128000.0 (Q2 2025), and $129000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 315,000.00 |
| Sep 30, 2025 | 315,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | 39.20 Mn |
| Dec 31, 2024 | 39.20 Mn |
| Sep 30, 2024 | -318,000.00 |
| Sep 30, 2024 | -318,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2022 | -49,000.00 |
| Sep 30, 2022 | -49,000.00 |
| Dec 31, 2021 | -3.29 Mn |
| Dec 31, 2021 | -3.29 Mn |
| Sep 30, 2021 | 425,000.00 |
| Sep 30, 2021 | 425,000.00 |
| Jun 30, 2021 | 2.45 Mn |
| Jun 30, 2021 | 2.45 Mn |
| Mar 31, 2021 | 418,000.00 |
| Mar 31, 2021 | 418,000.00 |
| Dec 31, 2020 | 64.82 Mn |
| Dec 31, 2020 | 64.82 Mn |
| Jun 30, 2020 | 64.60 Mn |
| Jun 30, 2020 | 64.60 Mn |
| Mar 31, 2020 | 1.12 Mn |
| Mar 31, 2020 | 1.12 Mn |
| Dec 31, 2019 | 60.87 Mn |
| Dec 31, 2019 | 60.87 Mn |
| Sep 30, 2019 | -850,000.00 |
| Sep 30, 2019 | -850,000.00 |
| Jun 30, 2019 | 287,000.00 |
| Jun 30, 2019 | 287,000.00 |
| Mar 31, 2019 | 563,000.00 |
| Mar 31, 2019 | 563,000.00 |
| Dec 31, 2018 | 92.97 Mn |
| Dec 31, 2018 | 92.97 Mn |
| Sep 30, 2018 | -92.97 Mn |
| Sep 30, 2018 | -92.97 Mn |
| Jun 30, 2018 | 89.90 Mn |
| Jun 30, 2018 | 89.90 Mn |